CARE RATINGS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,172 INR | +0.43% |
|
+8.53% | +23.17% |
| Mar. 19 | CARE Gets Board Nod for New Subsidiary in GIFT City, India | MT |
| Mar. 19 | CARE Ratings Limited Approves Incorporation of Wholly-Owned Subsidiary in GIFT City, Gujarat | CI |
Valuation
| Fiscal Period: Marzo | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 29,155 | 9,644 | 12,109 | 15,133 | 19,092 | 35,007 | - | - |
| Enterprise Value (EV) 1 | 29,155 | 9,644 | 12,109 | 15,133 | 19,092 | 35,007 | 35,007 | 35,007 |
| P/E ratio | 21.2 x | 11.7 x | 13.6 x | 20.2 x | 22.8 x | 32.3 x | 26.6 x | 23.4 x |
| Yield | 3.03% | 5.96% | 6.08% | 3.33% | 2.64% | 1.89% | 2.55% | 2.99% |
| Capitalization / Revenue | 9.14 x | 3.96 x | 4.87 x | 6.11 x | 6.68 x | 10.5 x | 9.26 x | 8.23 x |
| EV / Revenue | 9.14 x | 3.96 x | 4.87 x | 6.11 x | 6.68 x | 10.5 x | 9.26 x | 8.23 x |
| EV / EBITDA | 16.7 x | 12 x | 12.6 x | 19 x | 19.2 x | 29.7 x | 24.5 x | 21.1 x |
| EV / FCF | 35.4 x | -28.1 x | 14.8 x | 30.9 x | 27 x | 31 x | 26.3 x | 23.1 x |
| FCF Yield | 2.82% | -3.56% | 6.75% | 3.24% | 3.71% | 3.23% | 3.81% | 4.34% |
| Price to Book | - | 1.81 x | - | 2.34 x | 2.67 x | 4.83 x | 4.55 x | 4.3 x |
| Nbr of stocks (in thousands) | 29,461 | 29,461 | 29,461 | 29,647 | 29,701 | 29,868 | - | - |
| Reference price 2 | 989.6 | 327.4 | 411.0 | 510.4 | 642.8 | 1,172 | 1,172 | 1,172 |
| Announcement Date | 5/21/19 | 6/18/20 | 6/12/21 | 5/29/22 | 5/11/23 | - | - | - |
1INR in Million2INR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 3,190 | 2,436 | 2,484 | 2,476 | 2,859 | 3,336 | 3,781 | 4,251 |
| EBITDA 1 | 1,747 | 803.9 | 957.7 | 798.2 | 993.4 | 1,179 | 1,429 | 1,660 |
| EBIT 1 | 1,713 | 726.2 | 879.7 | 721.2 | 945.2 | 1,075 | 1,310 | 1,522 |
| Operating Margin | 53.72% | 29.81% | 35.41% | 29.12% | 33.05% | 32.22% | 34.65% | 35.8% |
| Earnings before Tax (EBT) 1 | 2,017 | 1,041 | 1,186 | 986.3 | 1,257 | 1,532 | 1,768 | 2,009 |
| Net income 1 | 1,375 | 823.7 | 895.2 | 751.1 | 835.3 | 1,080 | 1,309 | 1,489 |
| Net margin | 43.1% | 33.81% | 36.03% | 30.33% | 29.21% | 32.37% | 34.62% | 35.03% |
| EPS 2 | 46.66 | 27.96 | 30.33 | 25.31 | 28.17 | 36.30 | 44.00 | 50.00 |
| Free Cash Flow 1 | 823.4 | -343.8 | 816.8 | 490.2 | 707.4 | 1,130 | 1,333 | 1,518 |
| FCF margin | 25.81% | -14.11% | 32.88% | 19.8% | 24.74% | 33.87% | 35.26% | 35.71% |
| FCF Conversion (EBITDA) | 47.14% | - | 85.29% | 61.41% | 71.21% | 95.84% | 93.28% | 91.45% |
| FCF Conversion (Net income) | 59.9% | - | 91.25% | 65.27% | 84.68% | 104.63% | 101.83% | 101.95% |
| Dividend per Share 2 | 30.00 | 19.50 | 25.00 | 17.00 | 17.00 | 22.20 | 29.90 | 35.10 |
| Announcement Date | 5/21/19 | 6/18/20 | 6/12/21 | 5/29/22 | 5/11/23 | - | - | - |
1INR in Million2INR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: March | 2022 Q2 | 2022 Q3 | 2022 Q4 |
|---|---|---|---|
| Net sales 1 | 763.9 | 561.7 | 658.8 |
| EBITDA 1 | 335.3 | 149.7 | 226.8 |
| EBIT | - | - | - |
| Operating Margin | - | - | - |
| Earnings before Tax (EBT) | - | - | - |
| Net income | - | - | - |
| Net margin | - | - | - |
| EPS | - | - | - |
| Dividend per Share | - | - | - |
| Announcement Date | 10/29/21 | 1/28/22 | 5/29/22 |
1INR in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | 823 | -344 | 817 | 490 | 707 | 1,130 | 1,333 | 1,518 |
| ROE (net income / shareholders' equity) | 24% | 15.2% | 16% | 12.2% | 13.2% | 15.4% | 17.6% | 18.9% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share 2 | - | 181.0 | - | 218.0 | 241.0 | 243.0 | 257.0 | 273.0 |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex 1 | 262 | 45.8 | 44.9 | 190 | 115 | 98 | 160 | 178 |
| Capex / Sales | 8.22% | 1.88% | 1.81% | 7.67% | 4.02% | 2.94% | 4.23% | 4.19% |
| Announcement Date | 5/21/19 | 6/18/20 | 6/12/21 | 5/29/22 | 5/11/23 | - | - | - |
1INR in Million2INR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
1,172
INR
Average target price
1,303
INR
Spread / Average Target
+11.17%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +23.17% | 420M | |
| -3.69% | 68.67B | |
| -8.12% | 606M | |
| +11.65% | 276M |
- Stock Market
- Equities
- CARERATING Stock
- Financials CARE Ratings Limited
